glp 1 drugs and autoimmune disease GLP-1 Obesity May Lower Risk of Heart for People With Disease Frontiers | The immunomodulatory effects

doi: 10.1155/2014/917981 33 CorkS

Gallwitz B, Guzman J, Dotta F, et al

At Noor Medical Spa, we offer innovative treatments like semaglutide therapy, including Ozempic and Wegovy, for weight loss and metabolic health

Originally developed to treat Type 2 diabetes, GLP-1 medications are now widely used for weight management

Similarly, observational studies using healthcare databases have suggested that patients prescribed GLP-1 agonists for diabetes or obesity appear to have lower rates of alcohol-related hospital admissions and reduced self-reported drinking compared to those on other medications, though these findings are limited by potential confounding factors

Consequently, businesses should rethink their operations and revenue streams to offer value that aligns with this new consumer ethos. Market research thus far has indicated that GLP-1 drugs may impact consumer spending on food and beverages namely, on candy and sugary snacks and drinks in shopping regularity, basket size and product choices as these medications affect eating habits in areas such as frequency, portion size and taste preferences